Tag: Imaging
-

From Human Retina to Artificial Eye: KRISS Sets a New Standard in Ophthalmic Imaging
Overview: A Breakthrough in Ophthalmic Imaging Researchers at the Korea Research Institute of Standards and Science (KRISS) have unveiled a retina-mimicking eye phantom that closely replicates the structural layers and microvascular network of the human retina. This innovative device, designed to emulate the eye’s complex optical and vascular features, promises to become a new standard…
-

Advancing Awareness and Innovation in Invasive Lobular Breast Cancer: Lessons from a Fred Hutch Event
Global Lobular Breast Cancer Day shines spotlight on ILC challenges and breakthroughs Last week, invasive lobular breast cancer (ILC) patients and their care teams gathered at Fred Hutch Cancer Center for a focused two-hour program. The event, held on October 15 to mark Global Lobular Breast Cancer Awareness Day, brought patient stories, epidemiological insights, and…
-

Data-Driven Cancer Care: How Dr. Omar Khan Is Rewriting Alberta’s Oncology Landscape
Turning Data Into Better Cancer Care In Calgary, Alberta, a physician-scientist is reshaping how cancer care is delivered by translating data into real-world improvements for patients. Dr. Omar Khan, a medical oncologist who treats breast cancer and sarcoma at the Arthur J.E. Child Comprehensive Cancer Centre (Arthur Child), has long believed that artificial intelligence and…
-

PSMA-PET/CT May Replace NaF-PET/CT in Advanced Prostate Cancer
PSMA-PET/CT Could Redefine Staging in High-Risk Prostate Cancer Imaging plays a pivotal role in determining treatment for men with newly diagnosed, high-risk prostate cancer. A recent Danish study suggests that replacing the conventional F-18 sodium fluoride (NaF) PET/CT with F-18 PSMA-PET/CT could significantly alter metastatic staging and, in turn, treatment decisions. The findings, published in…
-

Unusual GLP-1 Drug Side Effect Could Skew PET-CT Scans, Study Warns
GLP-1 drugs are reshaping weight loss—and now imaging, too GLP-1 receptor agonists, best known by brand names like Ozempic, Wegovy, and Mounjaro, have surged in popularity for their powerful weight‑loss effects. But as their use has exploded—driven by a 700% rise in the United States from 2019 to 2023—so too have reports of unusual side…
-

Non-Accidental Trauma in Infants: Recognition and Care Protocols
Understanding Non-Accidental Trauma in Infants Non-accidental trauma (NAT) refers to physical injury inflicted by a caregiver or another person, rather than by accidental causes. In infants, NAT poses a particular diagnostic challenge because early injuries can be subtle, nonspecific, or concealed within occult trauma affecting bones, the brain, or internal organs. A sentinel injury—such as…
-

Tech Highlights of the Week: Xiaomi, Huawei, BYD and Beyond
This Week in Tech: A Roundup of Bold Moves from Smartphones to Speed Machines The last seven days delivered a wide spectrum of technology news, spanning consumer devices, mobility breakthroughs, and software innovations. From Xiaomi’s new lineup and a flagship smartwatch to a record-setting electric car and advances in imaging and AI, here’s a concise…

